A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer

A phase I/II trial of concurrent immunotherapy with chemoradiation in locally advanced larynx cancer

Abstract Objectives Cisplatin‐based chemoradiation is an established organ‐preserving strategy for locally advanced laryngeal cancer, but long‐term survival remains suboptimal. Immunotherapy has been studied in the metastatic and unresectable recurrent settings. However, additional data are needed t...

Full description

Bibliographic Details
Main Authors: Andrew J. Frankart, Nooshin Hashemi Sadraei, Brad Huth, Kevin P. Redmond, William L. Barrett, Nicky Kurtzweil, Muhammad K. Riaz, Trisha Wise‐Draper, Cristina P. Rodriguez, David J. Adelstein, Vinita Takiar
Format: Article
Language:English
Published: Wiley 2022-04-01
Series:Laryngoscope Investigative Otolaryngology
Subjects:
chemotherapy
immunology
laryngeal cancer/vocal fold dysplasia
organ preservation
radiation therapy
Online Access:https://doi.org/10.1002/lio2.780

Internet

https://doi.org/10.1002/lio2.780

Similar Items